TGTX
TG Therapeutics Inc
-19.05%
$18.43 - $14.92
Feb 7th 2023 - Mar 21st 2023
Jan, 30, 2023
Translate the data on this (today's sec releas... See more
Jan, 4, 2023
Approved, best in class drug with a huge market an... See more
Divihomes is Now Live
A new search platform that matches you with the best home improvement service providers in your area.
Instant Search & Match with Top Contractors
Instant Communication with Local Contractors
Millions of Unbiased User Reviews
100% Free Quotes from Top-Notch Contractors
INM
InMed Pharmaceuticals Inc
-31.19%
$2.02 - $1.39
Feb 7th 2023 - Mar 21st 2023
Mar, 12, 2023
Company doubled in size and reduced cash burn with... See more
Jan, 13, 2023
This stock is solid on cash, has a low float, and ... See more
Feb, 16, 2023
A massive cash infusion would be perfect here. .
Jan, 13, 2023
$HTGM A penny with cash and increasing revenue.
Jan, 12, 2023
And no silent dilutions like avxl , reason cash stays steady 🐀🤦🏻♂️🤦🏻♂️🤦🏻♂️😂😂
Jan, 12, 2023
Strong cash runway for 4 years
Jan, 12, 2023
$AVXL wow enough cash for 4yrs
Dec, 3, 2022
Best part some of their studies/trials are sponsored ie:Michael J Fox Foundation for Parkinsons, company says with the $150mm in cash that was on the balance sheet at quarter end is sufficient enough to take them through the next 4 years.
Dec, 3, 2022
$AVXL I will be working the weekend to gather more cash and buy more.
Nov, 28, 2022
Like lighting cash on 🔥
Nov, 14, 2022
another conference reharshing the same old stuff in front of new investors, confirming that he needs cash and plans to dilute and no collaborations or deals are close. Amazing!!
Nov, 11, 2022
$AVXL wish I had more cash to buy more !!
Jan, 30, 2023
Translate the data on this (today's sec release) Seems VERY positive and with a cash run into 2024 on worst case basis.
Jan, 4, 2023
Approved, best in class drug with a huge market and a nice pile of cash, it checks every box.
Dec, 29, 2022
Amazing positive news from the TGTX 20221229 conference call, FDA approved, 🚨🔥🚨 Ublituximab Briumvi: 1) No need for additional funds, no offering, no need for capital raise, because 220 million in cash reserves expected to last until mid 2024.
Dec, 29, 2022
$TGTX Plenty of cash on hand and commercialization up and coming.
Mar, 12, 2023
Company doubled in size and reduced cash burn with no risk of dilution.
Jan, 13, 2023
This stock is solid on cash, has a low float, and is a standout in a unique market.
Jan, 12, 2023
->It is trading at less than 30% of cash value with a great pipeline and priducts.
Dec, 29, 2022
$INM Hardly any debt!🤓
Dec, 29, 2022
$INM Nice cash position!💪🦁👍